The Medical letter on drugs and therapeutics·
GLP-1 and GIP/GLP-1 receptor drugs for long-term weight control
Updated
Related papers
Jun '17
A new GIP-like drug, ZP4165, boosts weight loss and blood sugar control caused by GLP-1 in rodents
cited by 115 papers
comparative study
Nov '21
Tirzepatide, a new medicine that activates two blood sugar hormones, as a potential heart and metabolism treatment
top 2% journal
cited by 106 papers
journal article
Dec '18
Improved GIP-like drugs reduce body weight in mice by activating, not blocking, GIP receptors
top 5% journal
cited by 206 papers
research support, non-u.s. gov't
Aug '16
How drugs that activate GLP-1 receptors help manage obesity
top 50% journal
cited by 60 papers
journal article
Sep '24
New developments in incretin drugs: from GLP-1 activators to combined and multi-target treatments
english abstract